Successful DCD kidney transplantation using early corticosteroid withdrawal

American Journal of Transplantation

Volumn 10, Issue 1, 2010, Pages 115-123

  Chudzinski, R E ^a   Khwaja, K ^a   Teune, P ^a   Miller, J ^a   Tang, H ^a   Pavlakis, M ^a   Rogers, C ^a   Johnson, S ^a   Karp, S ^a   Hanto, D ^a   Mandelbrot, D ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cardiac death donors; Corticosteroid withdrawal; Kidney transplantation

Indexed keywords

BASILIXIMAB; CREATININE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CADAVER DONOR; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DELAYED GRAFT FUNCTION; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART DEATH; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

EID: 72549108950     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02922.x     Document Type: Article

References (27)

1. Leichtman AB, Cohen D, O'Connor K et al. Kidney and pancreas transplantation in the United States, 1997-2206: The HRSA rreakthrough coolaboratives and the 58 DSA challenge. Am J Transplant 2008 8 (Pt 2 946 957.
2. OPTN 2007 (SRTR Annual Report. Table 2.2 Deceased Donor Characteristics, 1997-2006.
3. Chapman J, Bock A, Dussol B et al. Follow-up after renal transplantation with organs from donors after cardiac death. Transpl Intl 2006 19 : 715 719.
4. Cooper JT, Chin LT, Krieger NR et al. Donation after cardiac death: The University of Wisconsin experience with renal transplantation. Am J Transplant 2004 4 : 1490 1494.
5. Whiting JF, Delmonico F, Morrissey P et al. Clinical results of an organ procurement organization effort to increase utilization of donors after cardiac death. Transplantation 2006 81 : 1368 1371.
6. Weber M, Dindo D, Demartines N, Ambühl PM, Clavien PA. Kidney transplantation from donors without a heartbeat. N Engl J Med 2002 347 : 248 255.
7. Doshi MD, Hunsicker LG. Short- and long-term outcomes with the use of kidneys and livers donated after cardiac death. Am J Transplant 2007 7 : 122 129.
8. Bernat JL, D'Alessandro AM, Port FK et al. Report of a National Conference on Donation after Cardiac Death. Am J Transplant 2006 6 : 281 291.
9. Rudich SM, Kaplan B, Magee JC et al. Renal transplantations performed using non-heart-beating organ donors: Going back to the future? Transplantation 2002 74 : 1715 1720.
10. Locke JE, Segev DL, Warren DS, Dominici F, Simpkins CE, Montgomery RA. Outcomes of kidneys from donors after cardiac death: Implications for allocation and preservation. Am J Transplant 2007 7 : 1797 1807.
11. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL. Delayed graft function: Risk factors and implications for renal allograft survival. Transplantation 1997 63 : 968 974.
12. Vincenti F, Schena FP, Paaskevas S, Hauser IA, Walker RG, Grinyo J, Freedom Study Group. A randomized, multicenter, study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transplant 2008 8 : 307 316.
13. Ekberg H, Tedesco-Silva H, Demirbas A et al, for the ELITE-Symphony Study. Reduced exposure to calcineurin inhibitors in renal transplantation. New Engl J Med 2007 357 : 2562 2575.
14. Woodle ES, Astellas Steroid Withdrawal Study Group. A prospective, randomized double-blind, placebo-controlled multicenter trial comparing of early (7 day) corticosteroid cessation versus long-term, low dose corticosteroid therapy. Annal Surg 2008 248 : 564 577.
15. Johnson SR, Pavlakis M, Khwaja K et al. Intensive care unit extubation does not preclude extrarenal organ recovery from donors after cardiac death. Transplantation 2005 80 : 1244 1250.
16. Farney A, Singh RP, Hines MH et al. Experience in renal and extrarenal transplantation with donation after cardiac death donors with selective use of extracorporeal support. J Am College Surgeons 2008 206 : 1028 1037.
17. Yarlagadda SG, Coca SG, Formica RN, Poggio ED, Parikh CR. Association between delayed graft function and allograft and patient survival: A systematic review and meta-analysis. Nephrol Dial Transplant 2009 24 : 1039 1047.
18. Andres B-F, Eckart T, Daniel C et al. Polyclonal antithymocyte globulins influence apoptosis in reperfused tissues after ischemia in a non-human primate model. Transpl Int 2004 17 : 453 457.
19. Chappell D, Beiras-Fernandez A, Hammer C, Thein E. In vivo visualization of the effect of polyclonal antithymocyte globulins on the microcirculation after ischemia(reperfusion in a primate model. Transplantation 2006 81 : 552 558.
20. Saidi RF, Elias N, Kawai T et al. Outcomes of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: Realities and costs. Am J Transplant 2007 7 : 2769 2774.
21. Ahsan N, Hricik D, Matas A et al. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - A prospective randomized study. Steroid Withdrawal Study Group. Transplantation 1999 68 : 1865 1874.
22. Chakrabarti P, Wong HY, Toyofuku A et al. Outcomes after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc 2001 33 : 1235 1236.
23. Squifflet JP, Vanrenterghem Y, van Hoof JP, Salmela K, Rigotti P, European Tacrolimus/MMF Transplantation Study Group. Safe withdrawal of corticosteroids or mycophenolate mofetil: Results of a large, prospective, randomized study. Transplant Proc 2002 34 : 1584 1586.
24. Mahalati K, Kahan BD. A pilot study of steroid withdrawal from kidney transplant recipients on sirolimus - Cyclosporine a combination therapy. Transplant Proc 2001 33 : 3232 3233.
25. Pascual J, Zamora J, Galeano C, Royuela A, Quereda C. Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Rev 2009 : CD005632.
26. Woodle ES, Alloway RR, Buell JF et al. Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression. Am J Transplant 2005 5 : 2740 2744.
27. Egbuna O, Davis RB, Chudinski R et al. Outcomes with conversion from calcineurin inhibitors to sirolimus after renal transplantation in the context of steroid withdrawal or steroid continuation. Transplantation 2009 88 : 684 692.